Literature DB >> 16620097

Tuning the coordination number of hydroxypyridonate-based gadolinium complexes: implications for MRI contrast agents.

Valérie C Pierre1, Mauro Botta, Silvio Aime, Kenneth N Raymond.   

Abstract

Eight-coordinate hydroxypyridinone/terephthalamide GdIII complexes display high relaxivities due to their two inner sphere water molecules. This relaxivity can be further increased by functionalizing the terephthalamide moiety with an amine. A significant hydrogen bonding interaction between the amine and another water molecule close to the GdIII apparently facilitates its coordination on the open site of the metal. The resulting nine-coordinate complex has three inner sphere water molecules, while maintaining high stability and fast ligand exchange rates.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16620097      PMCID: PMC3188315          DOI: 10.1021/ja057805x

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  9 in total

1.  Gadolinium(III) Chelates as MRI Contrast Agents: Structure, Dynamics, and Applications.

Authors:  P Caravan; J J Ellison; T J McMurry; R B Lauffer
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

Review 2.  Next generation, high relaxivity gadolinium MRI agents.

Authors:  Kenneth N Raymond; Valérie C Pierre
Journal:  Bioconjug Chem       Date:  2005 Jan-Feb       Impact factor: 4.774

3.  Syntheses and relaxation properties of mixed gadolinium hydroxypyridinonate MRI contrast agents.

Authors:  S M Cohen; J Xu; E Radkov; K N Raymond; M Botta; A Barge; S Aime
Journal:  Inorg Chem       Date:  2000-12-11       Impact factor: 5.165

4.  Mixed hydroxypyridinonate ligands as iron chelators.

Authors:  S M Cohen; B O'Sullivan; K N Raymond
Journal:  Inorg Chem       Date:  2000-09-18       Impact factor: 5.165

5.  In vivo evaluation of gadolinium hydroxypyridonate chelates: initial experience as contrast media in magnetic resonance imaging.

Authors:  Marlon K Thompson; Bernd Misselwitz; Luke S Tso; Dan M J Doble; Heribert Schmitt-Willich; Kenneth N Raymond
Journal:  J Med Chem       Date:  2005-06-02       Impact factor: 7.446

6.  Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.

Authors:  Jide Xu; David G Churchill; Mauro Botta; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2004-09-06       Impact factor: 5.165

7.  Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.

Authors:  Dan M J Doble; Marco Melchior; Brendon O'Sullivan; Carsten Siering; Jide Xu; Valérie C Pierre; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2003-08-11       Impact factor: 5.165

8.  Structural, luminescence, and NMR studies of the reversible binding of acetate, lactate, citrate, and selected amino acids to chiral diaqua ytterbium, gadolinium, and europium complexes.

Authors:  Rachel S Dickins; Silvio Aime; Andrei S Batsanov; Andrew Beeby; Mauro Botta; James I Bruce; Judith A K Howard; Christine S Love; David Parker; Robert D Peacock; Horst Puschmann
Journal:  J Am Chem Soc       Date:  2002-10-30       Impact factor: 15.419

9.  A highly stable gadolinium complex with a fast, associative mechanism of water exchange.

Authors:  Marlon K Thompson; Mauro Botta; Gaëlle Nicolle; Lothar Helm; Silvio Aime; André E Merbach; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2003-11-26       Impact factor: 15.419

  9 in total
  16 in total

1.  Strategies for the preparation of bifunctional gadolinium(III) chelators.

Authors:  Luca Frullano; Peter Caravan
Journal:  Curr Org Synth       Date:  2011-08-01       Impact factor: 1.975

2.  New Synthetic Approach for the Incorporation of 3,2-Hydroxypyridinone (HOPO) Ligands: Synthesis of Structurally Diverse Poly HOPO Chelators.

Authors:  Jayanthi Arumugam; Hayley A Brown; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Synthesis (Stuttg)       Date:  2011-01-01       Impact factor: 3.157

3.  Substituent effects on Gd(III)-based MRI contrast agents: optimizing the stability and selectivity of the complex and the number of coordinated water molecules.

Authors:  Valérie C Pierre; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2006-10-02       Impact factor: 5.165

4.  New methodology for the preparation of 3-hydroxy-2-pyridinone (3,2-HOPO) chelators and extractants. Part 2. Reactions of alcohols, phenols, and thiols with an electrophilic 3,2-HOPO reagent().

Authors:  Sumathi Chittamuru; Timothy N Lambert; Gloria Martinez; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2007-01-20       Impact factor: 2.415

5.  Highly soluble tris-hydroxypyridonate Gd(III) complexes with increased hydration number, fast water exchange, slow electronic relaxation, and high relaxivity.

Authors:  Eric J Werner; Stefano Avedano; Mauro Botta; Benjamin P Hay; Evan G Moore; Silvio Aime; Kenneth N Raymond
Journal:  J Am Chem Soc       Date:  2007-01-30       Impact factor: 15.419

6.  Effect of a mesitylene-based ligand cap on the relaxometric properties of Gd(III) hydroxypyridonate MRI contrast agents.

Authors:  Eric J Werner; Mauro Botta; Silvio Aime; Kenneth N Raymond
Journal:  Contrast Media Mol Imaging       Date:  2009 Sep-Oct       Impact factor: 3.161

Review 7.  Design of a novel class of protein-based magnetic resonance imaging contrast agents for the molecular imaging of cancer biomarkers.

Authors:  Shenghui Xue; Jingjuan Qiao; Fan Pu; Mathew Cameron; Jenny J Yang
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2013-01-17

8.  3,2-Hydroxypyridinone (3,2-HOPO) vinyl sulfonamide and acrylamide linkers: Aza-Michael addition reactions and the preparation of poly-HOPO chelators.

Authors:  Gloria Martinez; Jayanthi Arumugam; Hollie K Jacobs; Aravamudan S Gopalan
Journal:  Tetrahedron Lett       Date:  2013-02-13       Impact factor: 2.415

9.  1,2-hydroxypyridonate/terephthalamide complexes of gadolinium(III): synthesis, stability, relaxivity, and water exchange properties.

Authors:  Eric J Werner; Julia Kozhukh; Mauro Botta; Evan G Moore; Stefano Avedano; Silvio Aime; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2009-01-05       Impact factor: 5.165

10.  Use of YbIII-centered near-infrared (NIR) luminescence to determine the hydration state of a 3,2-HOPO-based MRI contrast agent.

Authors:  Evan G Moore; Michael Seitz; Kenneth N Raymond
Journal:  Inorg Chem       Date:  2008-08-26       Impact factor: 5.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.